References
- Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry 1985: 42(3): 225–32
- Hammond EC. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health 1964: 54(Jan): 11–23
- Everitt DE, Avorn J, Baker MW. Clinical decision-making in the evaluation and treatment of insomnia. Am J Med 1990: 89(3): 357–62 [erratum, Am J Med 1990: 89(6): 838]
- Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA 1989: 262(11): 1479–84
- Survey of the United States public concerning the quality of sleep. Gallup Organization, 1986
- Kripke DF, Simons RN, Garfinkel L, et al. Short and long sleep and sleeping pills: is increased mortality associated? Arch Gen Psychiatry 1979: 36(1): 103–16
- Diagnostic Classification Steering Committee. International classification of sleep disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Assoc, 1990
- Czeisler CA, Richardson GS, Coleman RM, et al. Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia. Sleep 1981: 4(1): 1–21
- Rosenthal NE, Joseph-Vanderpool JR, Levendosky AA, et al. Phase-shifting effects of bright morning light as treatment for delayed sleep phase syndrome. Sleep 1990: 13(4): 354–61
- Montplaisir J, Godbout R. Restless legs syndrome and periodic movements during sleep. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. Philadelphia: WB Saunders, 1989: 402–9
- Oswald I, French C, Adam K, et al. Benzodiazepine hypnotics remain effective for 24 weeks. BMJ (Clin Res) 1982: 284(6319): 860–3
- Leibowitz M, Sunshine A. Long-term hypnotic efficacy and safety of triazolam and flurazepam. J Clin Pharmacol 1978: 18(5–6): 302–9
- Mitler MM, Browman CP, Menn SJ, et al. Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam. Sleep 1986: 9(3): 385–92
- Doghramji K, Browman CP, Gaddy JR, et al. Triazolam diminishes daytime sleepiness and sleep fragmentation in patients with periodic leg movements in sleep. J Clin Psychopharm (in press)
- Guilleminault C. Clinical features and evaluation of obstructive sleep apnea. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. Philadelphia: WB Saunders, 1989: 552–8
- Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987: 10(4): 541–53
- National Institutes of Mental Health. Drugs and insomnia: the use of medications to promote sleep. JAMA 1984: 251(18): 2410–4
- Divoll M, Greenblatt DJ, Harmatz JS, et al. Effect of age and gender on disposition of temazepam. J Pharm Sci 1981: 70(10): 1104–7
- Jochemsen R, Wesselman JG, van Boxtel CJ. Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects. Br J Clin Pharmacol 1983: 16(2 Suppl): 291–7S
- Scharf MB, Saskin P, Fletcher K. Benzodiazepine induced amnesia: clinical laboratory findings. J Clin Psychiatry 1987: 5: 14–7
- Pierce MW, Shu VS, Groves LJ. Safety of estazolam. The United States clinical experience. Am J Med 1990: 88(3A Suppl): 12–7S